Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 32% ± 18% | |
peripheral blood | 10 studies | 23% ± 7% | |
lung | 10 studies | 27% ± 11% | |
intestine | 8 studies | 25% ± 12% | |
eye | 7 studies | 27% ± 7% | |
kidney | 5 studies | 24% ± 3% | |
adipose | 4 studies | 20% ± 4% | |
placenta | 3 studies | 30% ± 3% | |
bone marrow | 3 studies | 17% ± 2% | |
skin | 3 studies | 25% ± 8% | |
lymph node | 3 studies | 27% ± 8% | |
liver | 3 studies | 36% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3315.79 | 1445 / 1445 | 100% | 48.54 | 183 / 183 |
ovary | 100% | 3227.23 | 180 / 180 | 100% | 44.53 | 430 / 430 |
stomach | 100% | 2044.91 | 359 / 359 | 100% | 49.79 | 286 / 286 |
brain | 100% | 3730.34 | 2637 / 2642 | 100% | 43.40 | 705 / 705 |
liver | 100% | 1717.88 | 226 / 226 | 100% | 44.91 | 405 / 406 |
skin | 100% | 4234.61 | 1807 / 1809 | 100% | 55.89 | 471 / 472 |
breast | 100% | 3212.11 | 459 / 459 | 100% | 68.25 | 1114 / 1118 |
uterus | 100% | 3393.06 | 170 / 170 | 100% | 70.57 | 457 / 459 |
pancreas | 100% | 2214.17 | 328 / 328 | 99% | 57.09 | 177 / 178 |
prostate | 100% | 2525.77 | 244 / 245 | 100% | 44.88 | 501 / 502 |
thymus | 100% | 2724.44 | 652 / 653 | 100% | 57.35 | 602 / 605 |
lung | 99% | 2498.66 | 574 / 578 | 100% | 53.09 | 1155 / 1155 |
bladder | 100% | 3127.38 | 21 / 21 | 99% | 58.02 | 500 / 504 |
adrenal gland | 100% | 2455.25 | 258 / 258 | 99% | 51.01 | 228 / 230 |
intestine | 100% | 3161.88 | 966 / 966 | 98% | 57.54 | 519 / 527 |
kidney | 100% | 2012.15 | 89 / 89 | 98% | 48.74 | 884 / 901 |
adipose | 100% | 4068.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5679.48 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 76.09 | 29 / 29 |
spleen | 100% | 2215.67 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 66.87 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.76 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 30.42 | 79 / 80 |
heart | 97% | 1902.24 | 836 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 3360.18 | 823 / 929 | 0% | 0 | 0 / 0 |
muscle | 81% | 805.11 | 647 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0036465 | Biological process | synaptic vesicle recycling |
GO_0046907 | Biological process | intracellular transport |
GO_0035654 | Biological process | clathrin-coated vesicle cargo loading, AP-3-mediated |
GO_0008089 | Biological process | anterograde axonal transport |
GO_0006886 | Biological process | intracellular protein transport |
GO_0048490 | Biological process | anterograde synaptic vesicle transport |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0060155 | Biological process | platelet dense granule organization |
GO_0006896 | Biological process | Golgi to vacuole transport |
GO_1903232 | Biological process | melanosome assembly |
GO_0016183 | Biological process | synaptic vesicle coating |
GO_0098793 | Cellular component | presynapse |
GO_0005769 | Cellular component | early endosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0030123 | Cellular component | AP-3 adaptor complex |
GO_0030133 | Cellular component | transport vesicle |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0030119 | Cellular component | AP-type membrane coat adaptor complex |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_1904115 | Cellular component | axon cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | AP3S1 |
Protein name | AP complex subunit sigma AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adaptor-related protein complex 3 subunit sigma-1) (Clathrin-associated/assembly/adaptor protein, small 3) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a) |
Synonyms | CLAPS3 |
Description | FUNCTION: Part of the AP-3 complex, an adaptor-related complex which is not clathrin-associated. The complex is associated with the Golgi region as well as more peripheral structures. It facilitates the budding of vesicles from the Golgi membrane and may be directly involved in trafficking to lysosomes. In concert with the BLOC-1 complex, AP-3 is required to target cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. FUNCTION: Part of the AP-3 complex, an adaptor-related complex which is not clathrin-associated. The complex is associated with the Golgi region as well as more peripheral structures. It facilitates the budding of vesicles from the Golgi membrane and may be directly involved in trafficking to lysosomes. In concert with the BLOC-1 complex, AP-3 is required to target cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. . |
Accessions | Q92572 F5H459 ENST00000316788.12 ENST00000506430.2 |